Global Medical REIT Inc.
Simbol: GMRE
NYSE
9.03
USDTržna cena danes
30.7150
Razmerje P/E
0.5877
Razmerje PEG
592.14M
Kapaciteta MRK
- 0.09%
Donos DIV
Global Medical REIT Inc. (GMRE) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 7.4 | 4 | 7.2 | |||||||||||||
balance-sheet.row.short-term-investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.net-receivables | 0 | 33.7 | 8.2 | 6.2 | |||||||||||||
balance-sheet.row.inventory | 0 | -25.1 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-current-assets | 0 | -41.1 | 18.3 | -50.3 | |||||||||||||
balance-sheet.row.total-current-assets | 0 | 14.4 | 30.5 | 24.9 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 7.6 | 3.5 | 3.8 | |||||||||||||
balance-sheet.row.goodwill | 0 | 5.9 | 5.9 | 5.9 | |||||||||||||
balance-sheet.row.intangible-assets | 0 | 66 | 148.1 | 127.9 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 71.9 | 154 | 133.8 | |||||||||||||
balance-sheet.row.long-term-investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.tax-assets | 0 | 1140.3 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 8.5 | 1205.3 | 1100.9 | |||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1253.3 | 1362.7 | 1238.5 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 0 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.account-payables | 0 | 12.8 | 13.8 | 10.3 | |||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.4 | 636.4 | 514.6 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 610.8 | 57.7 | 57.2 | |||||||||||||
Deferred Revenue Non Current | 0 | 5.1 | 4.4 | 3.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 0 | 601.1 | 11.4 | 15.7 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 42.5 | 78.1 | 85.3 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 13 | 10.5 | 8.1 | |||||||||||||
balance-sheet.row.total-liab | 0 | 661.9 | 744.2 | 625.9 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 75 | 75 | 75 | |||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||
balance-sheet.row.retained-earnings | 0 | -239 | -198.7 | -157 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 25.1 | 34.7 | -6.6 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 722.4 | 722 | 711.4 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 583.6 | 633 | 622.8 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 22.2 | 16.1 | 14.8 | |||||||||||||
balance-sheet.row.total-equity | 0 | 605.8 | 649.1 | 637.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||
Total Investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.total-debt | 0 | 624.2 | 694.1 | 571.7 | |||||||||||||
balance-sheet.row.net-debt | 0 | 616.8 | 690.1 | 564.5 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 20.6 | 20 | 18.3 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 58.1 | 57.7 | 47.3 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -122.1 | 0 | -0.9 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 4.2 | 4.7 | 5.8 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -5.7 | -1.7 | -3.8 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0.4 | -3 | -0.7 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0.2 | ||||||||||||
cash-flows.row.account-payables | 0 | -2 | 4.1 | 1.9 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -4.1 | -2.8 | -5.3 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 113.3 | -4.1 | 2.2 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 2 | 2.8 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -2.8 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 86.1 | 11.1 | 4.4 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | -1.3 | 7.8 | 2.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 74.8 | -137.3 | -194.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | -86.1 | -16.7 | -232.2 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 9.9 | 205.5 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 221.6 | ||||||||||||
cash-flows.row.dividends-paid | 0 | -64.8 | -64.2 | -58.3 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 133.4 | -8.9 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -150.9 | 62.4 | 127.7 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -77.5 | 0 | 0 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -14.9 | 1.7 | 2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 7.4 | 14.5 | 12.8 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 22.3 | 12.8 | 10.8 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 68.4 | 76.5 | 69 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | 58.4 | -79.7 | -132.7 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 156.7 | 137.3 | 115.9 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 86.2 | 25.2 | 15.5 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 70.4 | 112.1 | 100.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 16.9 | 73.3 | 63.3 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 103.1 | 98.5 | 78.8 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 58.1 | 57.7 | 46.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 53.5 | 38.8 | 37.1 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 21.7 | 20 | 18.3 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1.1 | 25.2 | 20.4 | ||||||||||||
income-statement-row.row.net-income | 0 | 20.6 | -5.2 | -2.1 |
Pogosto zastavljeno vprašanje
Kaj je Global Medical REIT Inc. (GMRE) skupna sredstva?
Global Medical REIT Inc. (GMRE) skupna sredstva so 1267700000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.759.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.891.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.134.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.345.
Kaj je Global Medical REIT Inc. (GMRE) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 20612000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 624193000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 16897000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.